home / stock / cprx / cprx quote
Last: | $15.13 |
---|---|
Change Percent: | 0.0% |
Open: | $15.34 |
Close: | $15.13 |
High: | $15.8 |
Low: | $15.03 |
Volume: | 7,421,049 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$15.13 | $15.34 | $15.13 | $15.8 | $15.03 | 7,421,049 | 04-19-2024 |
$15.34 | $16.03 | $15.34 | $16.25 | $15.33 | 1,493,313 | 04-18-2024 |
$16 | $15.7 | $16 | $16.06 | $15.62 | 1,367,280 | 04-17-2024 |
$15.54 | $15.22 | $15.54 | $15.69 | $15.1579 | 919,898 | 04-16-2024 |
$15.39 | $15.49 | $15.39 | $15.87 | $15.36 | 1,296,910 | 04-15-2024 |
$15.22 | $15.86 | $15.22 | $15.86 | $15.08 | 859,560 | 04-12-2024 |
$15.81 | $15.94 | $15.81 | $16.06 | $15.52 | 738,739 | 04-11-2024 |
$15.88 | $15.41 | $15.88 | $15.97 | $15.25 | 1,042,960 | 04-10-2024 |
$15.79 | $15.53 | $15.79 | $15.815 | $15.4201 | 844,995 | 04-09-2024 |
$15.51 | $15.29 | $15.51 | $15.905 | $15.17 | 930,173 | 04-08-2024 |
$15.17 | $15.02 | $15.17 | $15.33 | $14.97 | 831,288 | 04-05-2024 |
$15.12 | $15.54 | $15.12 | $15.62 | $15.065 | 796,713 | 04-04-2024 |
$15.49 | $15.21 | $15.49 | $15.5 | $15.05 | 993,862 | 04-03-2024 |
$15.26 | $15.45 | $15.26 | $15.46 | $15.14 | 1,095,949 | 04-02-2024 |
$15.74 | $15.79 | $15.74 | $15.86 | $15.35 | 1,005,851 | 04-01-2024 |
$15.94 | $16.29 | $15.94 | $16.5 | $15.775 | 1,172,375 | 03-29-2024 |
$15.94 | $16.29 | $15.94 | $16.5 | $15.775 | 1,172,375 | 03-28-2024 |
$16.27 | $15.9 | $16.27 | $16.665 | $15.89 | 1,471,658 | 03-27-2024 |
$15.75 | $16 | $15.75 | $16.14 | $15.73 | 828,267 | 03-26-2024 |
$15.86 | $15.77 | $15.86 | $16.03 | $15.6701 | 1,085,212 | 03-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
Catalyst Pharmaceuticals Inc. Company Name:
CPRX Stock Symbol:
NASDAQ Market:
Catalyst Pharmaceuticals Inc. Website:
CORAL GABLES, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (NASDAQ:CPRX), a commercial-stage, pa...
CORAL GABLES, Fla., March 28, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and ...
CORAL GABLES, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (NASDAQ:CPRX), a commercial-stage bio...